arrow
F

Francesco Mannelli

azienda ospedaliero-universitaria careggi
H指数:34
被引数:4,729

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clofarabine and intermediate-dose cytarabine after venetoclax failure in relapsed/refractory acute myeloid leukemia: a retrospective single-center experience

克洛拉拉滨联合中剂量阿糖胞苷在维奈克拉耐药后的复发/难治性急性髓系白血病中的应用:一项回顾性单中心经验

2026-11-040
OAAI
Transcriptomic profile and endothelial changes during differentiation syndrome in acute promyelocytic leukemia

急性早幼粒细胞白血病分化综合征期间的转录组谱和内皮变化

2026-09-020
OAAI
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications

NPM1突变AML中APL样亚群:一种与早期血管并发症相关的独特免疫表型

2026-04-160
OA
Clinical Experience With Venetoclax-Based Combinations for Relapsed/Refractory or MRD-Positive NPM1-Mutated Acute Myeloid Leukemia

基于Venetoclax的联合方案在复发/难治或MRD阳性NPM1突变急性髓系白血病中的临床经验

2026-04-010
OAAI
Genomic structural variations contribute to inform prognosis in patients with cytogenetically normal acute myeloid leukemia

基因组结构变异有助于为细胞遗传学正常的急性髓系白血病患者提供预后信息。

2026-03-060
OAAI
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351.

根据SIE/SIES/GITMO标准对治疗相关和aml-mrc接受CPX-351的适应性分类的影响。

2025-12-110
OAAI
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic Stem Cell Transplantation

真实世界研究:异基因干细胞移植的最佳CPX-351治疗时长与时机

2025-09-240
OAAI
Prognostic stratification in venetoclax-based acute myeloid leukemia treatments: the molecular prognostic risk signature tested in a real-world setting
2024-09-050
OAAI
Underlying systemic mastocytosis in patients with unexplained osteoporosis: score proposal
BONE
IF3.6
2024-09-011
PRE
Clinical impact of mutated JAK2 allele burden reduction in polycythemia vera and essential thrombocythemia
2024-06-067
PRE
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
2024-05-303
OAAI
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis
2024-04-290
PRE
Clonal dynamics and copy number variants by single-cell analysis in leukemic evolution of myeloproliferative neoplasms
2023-07-0310
OAAI